Article
RUVBL1 and RUVBL2 as novel druggable DNA Damage Response regulators in the N-Myc regulatory network in neuroblastoma
2023-11-20
Abstract excerpt
<title>Abstract</title> <p>High-risk neuroblastoma (NB) accounts for about 50% of all cases. These tumours are characterized by <italic>MYCN</italic> amplification and high <italic>MYC</italic> gene expression and patients have a high relapse rate despite intensive therapies, hence the need for safer and more effective drugs. Strategies to develop inhibitors that directly target the MYC proteins have been elusive...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 99a91ef2-82d1-5c6d-a451-2d404ad29ac2
- DOI
- 10.21203/rs.3.rs-3206227/v1
